Clinical Trials Browser

Enrolling by invitation × Interventional × sacituzumab govitecan × Clear all

NCT07359404 2026-01-22

Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC

Phase 2 Enrolling by invitation

Advanced Breast Cancer